L. Call

A Small-Molecule Inhibitor of PIM Kinases as a Potential Treatment for Urothelial Carcinomas

S. Kanner, Yong Xu, S. Tripp, 2014, Neoplasia.

Fragment-based design, synthesis, biological evaluation, and SAR of 1H-benzo[d]imidazol-2-yl)-1H-indazol derivatives as potent PDK1 inhibitors.

D. Bearss, S. Warner, H. Vankayalapati, 2017, Bioorganic & medicinal chemistry letters.

Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors.

Anupam Verma, D. Bearss, S. Warner, 2011, ACS medicinal chemistry letters.

Abstract 1875: A novel series of metabolic activators of PKM2 alter oncogene-meditated changes in tumor cell metabolism.

D. Bearss, S. Warner, B. Stephens, 2013 .